Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Medrxiv : the Preprint Server for Health Sciences
|
May 27, 2024
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
JAMA Network Open
|
October 18, 2024
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Kenneth C Anderson, Daniel Auclair, Stacey J Adam, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
JAMA
|
July 10, 2023
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Medrxiv : the Preprint Server for Health Sciences
|
May 27, 2024
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
JAMA Network Open
|
October 18, 2024
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Kenneth C Anderson, Daniel Auclair, Stacey J Adam, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
JAMA
|
July 10, 2023
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, et al.
Page
of 5